Clinical Trial: JSP191 (Briquilimab) in Subjects With LR-MDS
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lower-risk Myelodysplastic Syndrome
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Open-label, Dose-escalation, Safety, and Tolerability Study of JSP191 as a Second-line Therapy in Subjects With Lower-Risk Myelodysplastic Syndrome (LR-MDS)
Brief Summary:
A Phase 1 study in subjects with LR-MDS to assess the safety and tolerability of JSP191 as a second-line therapy.
Read more